Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: Expression of IL-15 receptor α on ATL cells

Blood

Volumn 91, Issue 11, 1998, Pages 4265-4272

  Yamada, Yasuaki ^a   Sugawara, Kazuyuki ^b   Hata, Tomoko ^b   Tsuruta, Kazuto ^b   Moriuchi, Ryozo ^b   Maeda, Takahiro ^b   Atogami, Sunao ^b   Murata, Ken ^b   Fujimoto, Kenshi ^b   Kohno, Tomoko ^b   Tsukasaki, Kunihiro ^b   Tomonaga, Masao ^b   Hirakata, Yo Ichi ^b   Kamihira, Shimeru ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; MONOCLONAL ANTIBODY;

ARTICLE; CELL INTERACTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

EID: 0032101533     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4265.411k06_4265_4272     Document Type: Article

References (38)

1. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson J, Alderson MR, Watson JD, Anderson DM, Giri JG: Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965, 1994
2. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA: A lymphokine, provisionally designated interleukin T and produced by a human adult T cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4935, 1994
3. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822, 1994
4. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM: Identification and cloning of a novel IL-15 binding protein that is structurally related to the a chain of the IL-2 receptor. EMBO J 14:3654, 1995
5. Smith KA: Interleukin-2: Inception, impact, and implications. Science 240:1169, 1988
6. Anderson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, Loomis A, Giri J, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Shapiro DN, Morris SW, Park LS, Cosman D: Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL-15RA and IL-2RA genes. J Biol Chem 270:29862, 1995
7. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H: Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50:481, 1977
8. Yamada Y: Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. Blood 61:192, 1983
9. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, Shirakawa S, Miyoshi I: Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78:6476, 1981
10. Poiesz BJ, Ruscetti FW, Gazdor AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415, 1980
11. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031, 1982
12. Bamford RN, Battiata AP, Burton J, Sharma H, Waldmann TA: Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many up stream AUGs that normally attenuate IL-15 mRNA translation. Proc Natl Acad Sci USA 93:2897, 1996
13. Bamford RN, Battiata AP, Waldmann TA: IL-15-The role of translational regulation in their expression. J Leukoc Biol 59:476, 1996
14. Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC: Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci USA 84:5389, 1987
15. Yamada Y, Nagata Y, Kamihira S, Tagawa M, Ichimaru M, Tomonaga M, Shiku H: IL-2-dependent ATL cell lines with phenotypes differing from the original leukemia cells. Leuk Res 15:619, 1991
16. Yamada Y, Fujita M, Suzuki H, Atogami S, Sohda H, Murata K, Tsukasaki K, Momita S, Kohno T, Maeda T, Joh T, Kamihira S, Shiku H, Tomonaga M: Established IL-2-dependent double-negative (CD4-/CD8-)TCR α β/CD3+ ATL cells: Induction of CD4 expression. Br J Haematol 88:234, 1994
17. Kohno T, Yamada Y, Hata T, Mori H, Yamamura M, Tomonaga M, Urata Y, Goto S, Kondo T: Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. J Immunol 156:4722, 1996
18. Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA: The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4940, 1994
19. Kumaki N, Anderson DM, Cosman D, Kumaki S: Expression of interleukin-15 and its receptor by human fetal retinal pigment epithelial cells. Curr Eye Res 15:876, 1996
20. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA: IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329, 1996
21. Munger W, Dejoy SQ, Jeyasseelan R, Torley LW, Grabstein KH, Eisenmann J, Paxton R, Cox T, Wick MM, Kerwar SS: Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: Comparison with interleukin-2. Cell Immunol 165:289, 1995
22. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA: Interleukin (IL) 15 is a novel cytokine that activates natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395, 1994
23. Girard D, Paquet ME, Paquin R, Beaulieu A: Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood 88:3176, 1996
24. Leclercq G, Debacker V, De Smedt M, Plum J: Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J Exp Med 184:325, 1996
25. Puzanov IJ, Bennett M, Kumar V: IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol 157:4282, 1996
26. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH: IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154:483, 1995
27. Kumaki S, Armitage R, Ahdieh M, Park L, Cosman D: Interleukin-15 up-regulates interleukin-2 receptor a chain but down-regulates its own high-affinity binding sites on human T and B cells. Eur J Immunol 26:1235, 1996
28. Dejong JLO, Farner NL, Widmer MB, Giri JG, Sondel PM: Interaction of IL-15 with the shared IL-2 receptor beta and gamma (c) subunits - The IL-15/beta/gamma(c) receptor-ligand complex. J Immunol 156:1339, 1996
29. Onu A, Pohl T, Krause H, Bulfone-Paus S: Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol 158:255, 1997
30. Mohamadzadeh M, Takashima A, Dougherty I, Knop J, Bergstresser PR: Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. J Immunol 155:4492, 1995
31. Wilkinson PC, Liew FY: Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 181:1255, 1995
32. McInnes JB, Al-Mughales J, Field M, Leung RP, Huang FP, Dixon R, Sturrock RD, Wilkinson RP, Liew FY: The role of interleukin-15 inT-cell migration and activation in rheumatoid arthritis. Nature Med 2:175, 1996
33. Yoshioka R, Yamaguchi K, Yoshinaga T, Takatsuki K: Pulmonary complication in patients with adult T-cell leukemia. Cancer 55:2491, 1985
34. Yamada Y, Kamihira S, Murata K, Yamamura M, Tsukasaki K, Jubashi T, Atogami S, Sohda H, Taguchi T, Tomonaga M: Frequent hepatic involvement in adult T cell leukemia: Comparison with non-Hodgkin's lymphoma. Leuk Lymphoma 26:327, 1997
35. Utsunomiya A, Hanada S, Terada A, Kodama M, Uematsu T, Tsukasa S, Hashimoto S, Tokunaga M: Adult T-cell leukemia with leukemia infiltration into the gastrointestinal tract. Cancer 61:824, 1988
36. Teshima T, Akashi K, Shibuya T, Taniguchi S, Okamura T, Harada M, Sumida I, Hanada M, Niho Y: Central nervous system involvement in adult T-cell leukemia/lymphoma. Cancer 65:327, 1990
37. Trentin L, Cerutti A, Zambello R, Sancetta R, Tassinari C, Facco M, Adami F, Rodeghiero F, Agostini C, Semenzato G: Interleukin-15 promoted the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood 87:3327, 1996
38. Zambello R, Facco M, Trentin L, Sancetta R, Tassinari C, Perin A, Milani A, Pizzolo G, Rodeghiero F, Agostini C, Meazza R, Ferrini S, Semenzato G: Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 89:201, 1997